Registro:

Referencias:

• Zhu, M.L., Kyprianou, N., Androgen receptor and growth factor signaling cross-talk in prostate cancer cells (2008) Endocr Relat Cancer, 15, pp. 841-849
• Roy, A.K., Tyagi, R.K., Song, C.S., Lavrovsky, Y., Ahn, S.C., Oh, T.S., Chatterjee, B., Androgen receptor: Structural domains and functional dynamics after ligand-receptor interaction (2001) Ann N Y Acad Sci, 949, pp. 44-57
• Lonard, D.M., O'Malley, B.W., Nuclear receptor coregulators: Judges, juries, and executioners of cellular regulation (2007) Mol Cell, 27, pp. 691-700
• O'Malley, B.W., Kumar, R., Nuclear receptor coregulators in cancer biology (2009) Cancer Res, 69, pp. 8217-8222
• Chun, J.Y., Nadiminty, N., Dutt, S., Lou, W., Yang, J.C., Kung, H.J., Evans, C.P., Gao, A.C., Interleukin-6 regulates androgen synthesis in prostate cancer cells (2009) Clin Cancer Res, 15, pp. 4815-4822
• Aydin, A., Arsova-Sarafinovska, Z., Sayal, A., Eken, A., Erdem, O., Erten, K., Ozgok, Y., Dimovski, A., Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia (2006) Clin Biochem, 39, pp. 176-179
• de Marzo, A.M., Platz, E.A., Sutcliffe, S., Xu, J., Gronberg, H., Drake, C.G., Nakai, Y., Nelson, W.G., Inflammation in prostate carcinogenesis (2007) Nat Rev Cancer, 7, pp. 256-269
• Jozkowicz, A., Was, H., Dulak, J., Heme oxygenase-1 in tumors: Is it a false friend? (2007) Antioxid Redox Signal, 9, pp. 2099-2117
• Wegiel, B., Chin, B.Y., Otterbein, L.E., Inhale to survive, cycle or die? Carbon monoxide and cellular proliferation (2008) Cell Cycle, 7, pp. 1379-1384
• Sacca, P., Meiss, R., Casas, G., Mazza, O., Calvo, J.C., Navone, N., Vazquez, E., Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer (2007) Br J Cancer, 97, pp. 1683-1689
• Gueron, G., de Siervi, A., Ferrando, M., Salierno, M., de Luca, P., Elguero, B., Meiss, R., Vazquez, E.S., Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells (2009) Mol Cancer Res, 7, pp. 1745-1755
• Ferrando, M., Gueron, G., Elguero, B., Giudice, J., Salles, A., Leskow, F.C., Jares-Erijman, E.A., Navone, N., Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer (2011) Angiogenesis, 14, pp. 467-479
• Ni, Z., Lou, W., Leman, E.S., Gao, A.C., Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells (2000) Cancer Res, 60, pp. 1225-1228
• Aaronson, D.S., Muller, M., Neves, S.R., Chung, W.C., Jayaram, G., Iyengar, R., Ram, P.T., An androgen-IL-6-Stat3 autocrine loop re-routes EGF signal in prostate cancer cells (2007) Mol Cell Endocrinol, 270, pp. 50-56
• Mora, L.B., Buettner, R., Seigne, J., Diaz, J., Ahmad, N., Garcia, R., Bowman, T., Cantor, A., Constitutive activation of Stat3 in human prostate tumors and cell lines: Direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells (2002) Cancer Res, 62, pp. 6659-6666
• Yamamoto, T., Sato, N., Sekine, Y., Yumioka, T., Imoto, S., Junicho, A., Fuse, H., Matsuda, T., Molecular interactions between STAT3 and protein inhibitor of activated STAT3, and androgen receptor (2003) Biochem Biophys Res Commun, 306, pp. 610-615
• Culig, Z., Androgen receptor cross-talk with cell signalling pathways (2004) Growth Factors, 22, pp. 179-184
• de Luca, P., Vazquez, E.S., Moiola, C.P., Zalazar, F., Cotignola, J., Gueron, G., Gardner, K., de Siervi, A., BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer (2011) Mol Cancer Res, 9, pp. 1078-1090
• Lin, Q., Weis, S., Yang, G., Weng, Y.H., Helston, R., Rish, K., Smith, A., Gaunitz, F., Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress (2007) J Biol Chem, 282, pp. 20621-20633
• Ueda, T., Bruchovsky, N., Sadar, M.D., Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways (2002) J Biol Chem, 277, pp. 7076-7085
• Bromberg, J.F., Wrzeszczynska, M.H., Devgan, G., Zhao, Y., Pestell, R.G., Albanese, C., Darnell Jr., J.E., Stat3 as an oncogene (1999) Cell, 98, pp. 295-303
• Liddle, F.J., Alvarez, J.V., Poli, V., Frank, D.A., Tyrosine phosphorylation is required for functional activation of disulfide-containing constitutively active STAT mutants (2006) Biochemistry, 45, pp. 5599-5605
• Bromberg, J.F., Horvath, C.M., Besser, D., Lathem, W.W., Darnell Jr., J.E., Stat3 activation is required for cellular transformation by v-src (1998) Mol Cell Biol, 18, pp. 2553-2558
• Liu, L., McBride, K.M., Reich, N.C., STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-α3 (2005) Proc Natl Acad Sci USA, 102, pp. 8150-8155
• Dayyani, F., Gallick, G.E., Logothetis, C.J., Corn, P.G., Novel therapies for metastatic castrate-resistant prostate cancer (2011) J Natl Cancer Inst, 103, pp. 1665-1675
• Devlin, H.L., Mudryj, M., Progression of prostate cancer: Multiple pathways to androgen independence (2009) Cancer Lett, 274, pp. 177-186
• Culig, Z., Santer, F.R., Androgen receptor co-activators in the regulation of cellular events in prostate cancer (2011) World J Urol, 30, pp. 297-302
• Culig, Z., Bartsch, G., Hobisch, A., Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth (2002) Mol Cell Endocrinol, 197, pp. 231-238
• Nakashima, J., Tachibana, M., Horiguchi, Y., Oya, M., Ohigashi, T., Asakura, H., Murai, M., Serum interleukin 6 as a prognostic factor in patients with prostate cancer (2000) Clin Cancer Res, 6, pp. 2702-2706
• Culig, Z., Steiner, H., Bartsch, G., Hobisch, A., Interleukin-6 regulation of prostate cancer cell growth (2005) J Cell Biochem, 95, pp. 497-505
• Aaronson, D.S., Horvath, C.M., A road map for those who don't know JAK-STAT (2002) Science, 296, pp. 1653-1655
• Tam, L., McGlynn, L.M., Traynor, P., Mukherjee, R., Bartlett, J.M., Edwards, J., Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer (2007) Br J Cancer, 97, pp. 378-383
• Abdulghani, J., Gu, L., Dagvadorj, A., Lutz, J., Leiby, B., Bonuccelli, G., Lisanti, M.P., Mirtti, T., Stat3 promotes metastatic progression of prostate cancer (2008) Am J Pathol, 172, pp. 1717-1728
• Blando, J.M., Carbajal, S., Abel, E., Beltran, L., Conti, C., Fischer, S., Digiovanni, J., Cooperation between Stat3 and Akt signaling leads to prostate tumor development in transgenic mice (2011) Neoplasia, 13, pp. 254-265
• Bonecchi, R., Locati, M., Mantovani, A., Chemokines and cancer: A fatal attraction (2011) Cancer Cell, 19, pp. 434-435
• Gueron, G., de Siervi, A., Vazquez, E., Key questions in metastasis: New insights in molecular pathways and therapeutic implications (2011) Curr Pharm Biotechnol, 12, pp. 1867-1880
• Chang, M., Kanwar, N., Feng, E., Siu, A., Liu, X., Ma, D., Jongstra, J., PIM kinase inhibitors downregulate STAT3(Tyr705) phosphorylation (2010) Mol Cancer Ther, 9, pp. 2478-2487
• Mohr, A., Chatain, N., Domoszlai, T., Rinis, N., Sommerauer, M., Vogt, M., Muller-Newen, G., Dynamics and non-canonical aspects of JAK/STAT signalling (2011) Eur J Cell Biol, 91, pp. 524-532
• Li, W.X., Canonical and non-canonical JAK-STAT signaling (2008) Trends Cell Biol, 18, pp. 545-551
• Levy, D.E., Lee, C.K., What does Stat3 do? (2002) J Clin Invest, 109, pp. 1143-1148
• Ridley, A.J., Schwartz, M.A., Burridge, K., Firtel, R.A., Ginsberg, M.H., Borisy, G., Parsons, J.T., Horwitz, A.R., Cell migration: Integrating signals from front to back (2003) Science, 302, pp. 1704-1709
• Yamashita, S., Miyagi, C., Fukada, T., Kagara, N., Che, Y.S., Hirano, T., Zinc transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrula organizer (2004) Nature, 429, pp. 298-302
• Silver, D.L., Naora, H., Liu, J., Cheng, W., Montell, D.J., Activated signal transducer and activator of transcription (STAT) 3: Localization in focal adhesions and function in ovarian cancer cell motility (2004) Cancer Res, 64, pp. 3550-3558
• Fan, Z.P., Lin, S.H., Cai, S.P., Ji, Y.J., Gao, F., Zhang, H.Y., Luo, S.Q., Zhang, W.J., An analysis of the clinical characteristics of patients with chronic hepatitis B superinfected with acute hepatitis E (2007) Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, 21, pp. 325-327
• Drachenberg, D.E., Elgamal, A.A., Rowbotham, R., Peterson, M., Murphy, G.P., Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer (1999) Prostate, 41, pp. 127-133
• Zhang, X., Shan, P., Jiang, G., Zhang, S.S., Otterbein, L.E., Fu, X.Y., Lee, P.J., Endothelial STAT3 is essential for the protective effects of HO-1 in oxidantinduced lung injury (2006) FASEB J, 20, pp. 2156-2158
• Ke, B., Shen, X.D., Ji, H., Kamo, N., Gao, F., Freitas, M.C., Busuttil, R.W., Kupiec-Weglinski, J.W., HO-1-STAT3 axis in mouse liver ischemia/reperfusion injury: Regulation of TLR4 innate responses through PI3K/PTEN signaling (2012) J Hepatol, 56, pp. 359-366
• Liu, M., Amodu, A.S., Pitts, S., Patrickson, J., Hibbert, J.M., Battle, M., Ofori-Acquah, S.F., Stiles, J.K., Heme mediated STAT3 activation in severe malaria (2012) PLoS One, 7, pp. e34280
• Zwirner, N.W., Croci, D.O., Domaica, C.I., Rabinovich, G.A., Overcoming the hurdles of tumor immunity by targeting regulatory pathways in innate and adaptive immune cells (2010) Curr Pharm Des, 16, pp. 255-267
• Xia, Z.W., Zhong, W.W., Meyrowitz, J.S., Zhang, Z.L., The role of heme oxygenase-1 in T cell-mediated immunity: The all encompassing enzyme (2008) Curr Pharm Des, 14, pp. 454-464
• Yu, H., Kortylewski, M., Pardoll, D., Crosstalk between cancer and immune cells: Role of STAT3 in the tumour microenvironment (2007) Nat Rev Immunol, 7, pp. 41-51
• Yoon, S., Woo, S.U., Kang, J.H., Kim, K., Shin, H.J., Gwak, H.S., Park, S., Chwae, Y.J., NF-κB and STAT3 cooperatively induce IL6 in starved cancer cells (2011) Oncogene, 31, pp. 3467-3481

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------